THeMaCHinE
New member
MS said:Anastrozole is less likely to alter her hormones enough to affect fat loss measurably. This does not make it a safer drug IMHO, just less effective. Even in males, anastozole only reduces circulating estrogens by ~50%, and it appears to have little effect on ovarian estrogen production in women, which is by far the largest source of female estrogens. However, she may increase her T levels somewhat with aromatase inhibitors. I dunno. It depends on how fat she is to begin with and how much peripheral E she produces as a result.
Interesting -- and I see your point about safeness/effectiveness.
So, blocking ovarian estrogen and blocking circulating estrogen are two different things? Blocking ovarian estrogen being the more desireable of the two? Ovarian estrogen doesn't circulate? Thanks for helping me understand these things.
Letrozole is significantly stronger, but may cause peripheral edema in some subjects. (interesting, just found that out: http://www.cc.nih.gov/phar/updates/98mayjun.html) Of course, the peripheral edema, if it did occure, would go away upon elimination of the drug from the system. I wonder if letrozole would yield any benefit?
I wonder how tamoxifen would fare?